NIH-funded research P01 program project

Coordinating efforts to improve HIV vaccine research

Official title: Administrative Core

Funded at Beth Israel Deaconess Medical Center · NIH-11084512 · Data updated 2026-11-12

This study is all about helping researchers work better together to create effective vaccines for HIV-1, which could eventually lead to better treatments for patients like you.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 11, 2023
Project endApril 30, 2028
Funding year2025
Award (this year)$172,900
NIH project number5P01AI177687-03
Project IDNIH-11084512 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation would be individuals at high risk for HIV or those interested in advancements in HIV vaccine development.

Less likely to help

Patients who are not at risk for HIV or those who are already living with HIV may not directly benefit from this research.

What this research studies

This research focuses on providing centralized administrative support to enhance the efficiency of various projects aimed at developing effective vaccines for HIV-1. It involves organizing regular meetings, maintaining regulatory compliance, and ensuring financial oversight to facilitate collaboration among researchers. By streamlining operations and communication, the project aims to keep all related studies on track and aligned with their goals. Patients may benefit indirectly as the research aims to improve the development of HIV vaccines through better coordination and management.

Why it matters

Potential benefit: If successful, this research could lead to more effective HIV vaccines, ultimately improving health outcomes for individuals at risk of HIV infection.

How similar studies have gone: Previous research has shown that effective coordination and administrative support can significantly enhance the outcomes of complex biomedical research projects.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Barouch, Dan H. — Beth Israel Deaconess Medical Center
  • Study coordinator: Barouch, Dan H.

Related research

Other NIH-funded projects on the same topics.

  • SATURN MRI ancillary study: statins after intracerebral hemorrhage and brain MRI markers

    This study looks at what happens to brain MRI markers and health outcomes when people with a specific type of brain bleed continue or stop taking statins.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625633

  • Statin use after brain bleed MRI study in ICH patients (SATURN MRI) Ancillary Study

    This project tests whether continuing or stopping statin therapy after an intracerebral hemorrhage affects brain changes seen on MRI and related health outcomes in people with lobar ICH.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625632

  • Statin use after brain bleed: SATURN MRI ancillary study

    This project tests whether continuing statin medicines after a brain bleed (lobar intracerebral hemorrhage) affects new brain blood vessel findings and long-term health.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625628

  • XenCAT: Single Cell Atlas for Xenopus

    Aims to map gene activity at the single-cell level in Xenopus to help understand how cells develop and how this relates to human disease.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11594482

  • Statin use after lobar intracerebral hemorrhage

    This trial compares continuing versus stopping statins in people who had a lobar intracerebral hemorrhage to see how that affects repeat brain bleeds, strokes, heart attacks, and recovery over two years.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11518526

  • Statin use after lobar brain hemorrhage

    This trial compares stopping versus continuing statin medicine in people who had a lobar brain bleed to learn effects on repeat bleeding and future heart or stroke events.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11518525

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.